SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 10.14 |
| Enterprise Value ($M) | 8.80 |
| Book Value ($M) | -1.32 |
| Book Value / Share | -0.49 |
| Price / Book | -7.68 |
| NCAV ($M) | -1.42 |
| NCAV / Share | -0.53 |
| Price / NCAV | -7.15 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -7.26 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.77 |
| Current Ratio | 0.77 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.76 |
| Assets | 4.85 |
| Liabilities | 6.17 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Zauderer Maurice | 16.60 | 10.83 | |
| 13G | Armistice Capital, Llc | 9.49 | ||
| 13D/A | Fcmi Parent Co. | 39.90 | 30.03 | |
| 13G | Point72 Asset Management, L.P. | 9.90 | ||
| 13G/A | Hirschman Orin | 9.90 | 1.11 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment Number 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 63,974 | 141,831 | 45.11 | |
| 7,025 | 35,807 | 19.62 | |
| 12,856 | 28,285 | 45.45 | |
| 7,422 | 59,760 | 12.42 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| UNCY – Unicycive Therapeutics, Inc. | UPC – Universe Pharmaceuticals INC |
| UPXI – Upexi, Inc. | VERU – Veru Inc. |
| VINC – Vincerx Pharma, Inc. |
Financial data and stock pages provided by
Fintel.io